Physician profile
Robert C Zoller
NPI 1821081225
$375.58
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $39.53 · 2021: $11.91.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $101.12 | 2019-2020 | |
| Therapeuticsmd, INC. | $39.98 | 2019 | |
| Allergan, INC. | $35.94 | 2019-2020 | |
| Avion Pharmaceuticals | $29.90 | 2019-2020 | |
| Duchesnay USA Incorporated | $28.47 | 2019 | |
| Mission Pharmacal Company | $26.58 | 2019 | |
| Astellas Pharma US INC | $23.19 | 2019 | |
| Sage Therapeutics, LLC | $16.25 | 2019 | |
| Daiichi Sankyo INC. | $14.04 | 2019 | |
| Pfizer INC. | $13.18 | 2019 | |
| Exeltis, USA INC. | $12.17 | 2019 | |
| Evofem Biosciences, INC. | $11.91 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.82 | 2019 | |
| Baxter Healthcare | $11.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Zoller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.